SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 58.34 |
| Enterprise Value ($M) | 32.92 |
| Book Value ($M) | 187.57 |
| Book Value / Share | 2.58 |
| Price / Book | 0.31 |
| NCAV ($M) | 173.28 |
| NCAV / Share | 2.38 |
| Price / NCAV | 0.34 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.49 |
| Return on Assets (ROA) | -0.36 |
| Return on Equity (ROE) | -0.40 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 11.66 |
| Current Ratio | 11.66 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 206.95 |
| Assets | 221.24 |
| Liabilities | 33.66 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 7.00 |
| Operating Income | -105.24 |
| Net Income | -101.87 |
| Earnings Per Share Basic And Diluted | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -81.64 |
| Cash from Investing | 76.05 |
| Cash from Financing | 0.64 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G | Barclays Plc | 5.27 | ||
| 13G/A | Avidity Partners Management LP | 6.90 | -25.90 | |
| 13G/A | Orbimed Advisors Llc | 2.70 | -44.87 | |
| 13G/A | Prosight Management, LP | 4.60 | -17.38 | |
| 13G/A | Suvretta Capital Management, Llc | 9.90 | 104.54 | |
| 13G/A | BlackRock Inc. | 6.60 | 13.86 | |
| 13G/A | State Street Corp | 1.54 | -73.76 | |
| 13G/A | Millennium Management Llc | 4.00 | -22.56 | |
| 13D/A | Morningside Venture Investments Ltd | 8.60 | 0.00 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| P UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 67,139 | 525,106 | 12.79 | |
| 75,294 | 380,167 | 19.81 | |
| 92,452 | 494,494 | 18.70 | |
| 108,792 | 178,683 | 60.89 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| KRYS – Krystal Biotech, Inc. | KURA – Kura Oncology, Inc. |
| KYTX – Kyverna Therapeutics, Inc. | LVTX – LAVA Therapeutics N.V. |
| LXRX – Lexicon Pharmaceuticals, Inc. |
Financial data and stock pages provided by
Fintel.io